Velcade Injection is indicated in the treatment and management of multiple myeloma and relapsed mantle cell lymphoma.
Detailed Description :
Generic Name: Bortezomib Velcade is a targeted therapy. It is classified as a proteasome inhibitor.
Velcade Is Used For:
Treatment of multiple myeloma.
Treatment of mantle cell lymphoma who have received at least one prior therapy.
How Velcade Is Given:
As an intravenous (into the vein) injection.
The amount of Velcade that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. Your doctor will determine your dose and schedule.